Trial NCT02418754

View at ClinicalTrials.gov 
Aliases: NCT02603484
Org. Study IDs: R2176-3-AMD-1417

Last trial update was posted on 2020-10-26

MeSH Interventions

Aflibercept

MeSH Conditions

Macular Degeneration Wet Macular Degeneration

Other Conditions

Neovascular Age-Related Macular Degeneration

Stopping Reasons

No additional efficacy seen with REGN2176-3 over aflibercept alone

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID